317 related articles for article (PubMed ID: 11692552)
41. Reticulum cell sarcoma in the course of Sjögren's syndrome.
Haritopoulos NC; Delikaris PG; Karamanakos PP
Int Surg; 1975 Aug; 60(8):423-4. PubMed ID: 1099043
[No Abstract] [Full Text] [Related]
42. [Characteristics of the patients with primary Sjögren's syndrome complicated with lymphoma].
Li YQ; Yu QM; Li J; Yang JR; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):467-9. PubMed ID: 22812260
[TBL] [Abstract][Full Text] [Related]
43. Pulmonary manifestations of primary Sjögren's syndrome.
Parke AL
Rheum Dis Clin North Am; 2008 Nov; 34(4):907-20, viii. PubMed ID: 18984411
[TBL] [Abstract][Full Text] [Related]
44. Sjögren's syndrome and nodular reticulum cell sarcoma.
Hornbaker JH; Foster EA; Williams GS; Davis JS
Arch Intern Med; 1966 Nov; 118(5):449-52. PubMed ID: 5332029
[No Abstract] [Full Text] [Related]
45. [The role of parotid gland biopsy in early detection of lymphoma in primary Sjogren's syndrome].
Vasil'iev VI; Logvinenko OA; Probatova NA; Kokosadze NV; Gorodetskiĭ VR; Kovrigina AM; Kondrat'eva TT; Mitrikov BV; Gaĭduk IV; Safonova TN; Simonova MV; Radenska-Lopovok SG; Varlamova EIu
Ter Arkh; 2009; 81(6):20-7. PubMed ID: 19663187
[TBL] [Abstract][Full Text] [Related]
46. Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma.
Somer BG; Tsai DE; Downs L; Weinstein B; Schuster SJ;
Arthritis Rheum; 2003 Jun; 49(3):394-8. PubMed ID: 12794796
[No Abstract] [Full Text] [Related]
47. [Lymphomas of the ocular adnexa in Gougerot-Sjögren syndrome. Apropos of 4 cases].
Chazerain P; Meyer O; Kaplan G; Brissaud P; Delmer A; Zufferey P; Kahn MF
Ann Med Interne (Paris); 1995; 146(4):223-5. PubMed ID: 7653938
[TBL] [Abstract][Full Text] [Related]
48. Sjögren's syndrome: a condition with features of chronic graft-versus-host disease: does duct cell adhesion or permeability play a role in pathogenesis?
Lamey PJ; Lundy FT; Al-Hashimi I
Med Hypotheses; 2004; 62(5):825-9. PubMed ID: 15082115
[TBL] [Abstract][Full Text] [Related]
49. [Sjögren's syndrome--risk of malignancy].
Fäldt R
Lakartidningen; 1972 Sep; 69(37):4050-1. PubMed ID: 4677742
[No Abstract] [Full Text] [Related]
50. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
Smedby KE; Baecklund E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
[TBL] [Abstract][Full Text] [Related]
51. An update on the management for the dental patient with Sjögren's syndrome and xerostomia.
Rhodus NL
Northwest Dent; 1999; 78(4):27-34. PubMed ID: 11819900
[TBL] [Abstract][Full Text] [Related]
52. Bilateral pulmonary nodules and mediastinal lymphadenopathy in a patient with Sjogren's syndrome.
Pathak V; Resnick JM; Islam T
WMJ; 2014 Feb; 113(1):32-4. PubMed ID: 24712219
[TBL] [Abstract][Full Text] [Related]
53. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
54. [Pathophysiology of Sjögren's syndrome].
Mariette X
Ann Med Interne (Paris); 2003 May; 154(3):157-68. PubMed ID: 12910042
[TBL] [Abstract][Full Text] [Related]
55. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
56. Dissemination of a Sjögren's syndrome-associated extranodal marginal-zone B cell lymphoma: circulating lymphoma cells and invariant mutation pattern of nodal Ig heavy- and light-chain variable-region gene rearrangements.
Hansen A; Reiter K; Pruss A; Loddenkemper C; Kaufmann O; Jacobi AM; Scholze J; Lipsky PE; Dörner T
Arthritis Rheum; 2006 Jan; 54(1):127-37. PubMed ID: 16385504
[TBL] [Abstract][Full Text] [Related]
57. [Malignant lymphoma associated with Sjögren's syndrome: a case report].
Kawauchi K; Sugiyama H; Watanabe S; Suzuki Y; Watanabe H
Rinsho Ketsueki; 1986 Jan; 27(1):84-9. PubMed ID: 3754909
[No Abstract] [Full Text] [Related]
58. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
59. [Lymphosarcoma of the parotid gland in Sjögren syndrom].
Bilder J; Hornová J
Cesk Stomatol; 1967 Nov; 67(6):441-6. PubMed ID: 16094991
[No Abstract] [Full Text] [Related]
60. Lymphoid complement of the human salivary glands: function and pathology.
Ciccone E; Truini M; Grossi CE
Eur J Morphol; 1998 Aug; 36 Suppl():252-6. PubMed ID: 9825932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
